Metraipolis › archive › dc_305da76a7ed2

Anticancer Acridones, Part 2-Acronycine-Type Derivatives Modified with 2,5-Dihydro-1,2,4-Triazine Moiety: Synthesis and In Vitro Evaluation — Europe PMC PMID:41752104

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41752104
DOI
10.3390/ijms27041969
License (as archived)
solo-consultazione
Archived
2026-11-05T16:32:43.623Z
SHA-256 of the archived text
d821a769f3776f329a81d2f3af0a59a83a5b62c49ef0c086c53f630992c8121c
Stable URL of this page
https://metraipolis.com/documento/dc_305da76a7ed2

How to cite

Anticancer Acridones, Part 2-Acronycine-Type Derivatives Modified with 2,5-Dihydro-1,2,4-Triazine Moiety: Synthesis and In Vitro Evaluation — Europe PMC PMID:41752104 — Europe PMC (en), https://europepmc.org/article/MED/41752104 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_305da76a7ed2 (Metraipolis archive dc_305da76a7ed2, sha256 d821a769f3776f329a81d2f3af0a59a83a5b62c49ef0c086c53f630992c8121c)
BibTeX
@misc{dc305da76a7ed2,
  title = {Anticancer Acridones, Part 2-Acronycine-Type Derivatives Modified with 2,5-Dihydro-1,2,4-Triazine Moiety: Synthesis and In Vitro Evaluation — Europe PMC PMID:41752104},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41752104},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_305da76a7ed2; sha256 d821a769f3776f329a81d2f3af0a59a83a5b62c49ef0c086c53f630992c8121c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41752104. Agents can read the archived copy with the MCP tool read_document.